Targeting PI3K/Akt signal transduction for cancer therapy

Yan He(Nanchang University), Bin Li(State Key Laboratory of Respiratory Disease)

Signal Transduction and Targeted Therapy

December 16, 2021

10.1038/s41392-021-00828-5

Cited by 1,739

Related Papers

Advances in targeted therapy for esophageal cancer

|Signal Transduction and Targeted Therapy|2020|546

Molecular mechanisms of chemo‐ and radiotherapy resistance and the potential implications for cancer treatment

|MedComm|2021|369

Significance of PI3K/AKT signaling pathway in metastasis of esophageal squamous cell carcinoma and its potential as a target for anti-metastasis therapy

|Oncotarget|2017|114

Anti-HIV Drug Elvitegravir Suppresses Cancer Metastasis via Increased Proteasomal Degradation of m6A Methyltransferase METTL3

|Cancer Research|2022|86

Combination of Hua Shi Bai Du granule (Q-14) and standard care in the treatment of patients with coronavirus disease 2019 (COVID-19): A single-center, open-label, randomized controlled trial

|Phytomedicine|2021|71